Connect with us

Turkish

Sirtex Medical announces new SIR-Spheres(R) DOORwaY-90 Study: The first prospective multicenter U.S.-based trial for registration as first-line treatment for hepatocellular carcinoma

Spread the love

… tissue. In countries outside the U.S., SIRT has been successfully … business with offices in the U.S., Australia, Europe and Asia, … Union (CE Mark), Switzerland, Turkey, and several countries in Asia … unresectable liver tumors. In the U.S., SIR-Spheres Y-90 …

Published

on

65 views